These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 38823417

  • 21. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 22. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 23. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 24. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 25. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 26. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
    Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ.
    J Clin Endocrinol Metab; 2012 Jun 15; 97(6):1887-96. PubMed ID: 22466349
    [Abstract] [Full Text] [Related]

  • 27. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK, Twardowska K.
    J Psychiatr Res; 1999 Jun 15; 33(5):363-70. PubMed ID: 10504004
    [Abstract] [Full Text] [Related]

  • 28. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.
    Heuser I, Yassouridis A, Holsboer F.
    J Psychiatr Res; 1994 Jun 15; 28(4):341-56. PubMed ID: 7877114
    [Abstract] [Full Text] [Related]

  • 29. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul 15; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 30. The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.
    Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB.
    Biol Psychiatry; 2008 Feb 15; 63(4):398-405. PubMed ID: 17825799
    [Abstract] [Full Text] [Related]

  • 31. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M.
    J Psychiatr Res; 2001 Feb 15; 35(2):83-94. PubMed ID: 11377437
    [Abstract] [Full Text] [Related]

  • 32. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C.
    Neuroendocrinology; 1999 Dec 15; 70(6):422-30. PubMed ID: 10657735
    [Abstract] [Full Text] [Related]

  • 33. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004 Dec 15; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 34. Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.
    Behnken A, Bellingrath S, Symanczik JP, Rieck MJ, Zavorotnyy M, Domschke K, Arolt V, Zwanzger P.
    Psychoneuroendocrinology; 2013 Mar 15; 38(3):447-54. PubMed ID: 22840287
    [Abstract] [Full Text] [Related]

  • 35. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
    Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH.
    Psychol Med; 2002 Aug 15; 32(6):1021-8. PubMed ID: 12214783
    [Abstract] [Full Text] [Related]

  • 36. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S, Wichers M, Klingmüller D, Höfer M, Lehmann LE, von Spiegel T, Hering R, Putensen C, Hoeft A, Stüber F.
    Crit Care Med; 2001 Feb 15; 29(2):310-6. PubMed ID: 11246311
    [Abstract] [Full Text] [Related]

  • 37. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
    Inder WJ, Joyce PR, Ellis MJ, Evans MJ, Livesey JH, Donald RA.
    Clin Endocrinol (Oxf); 1995 Sep 15; 43(3):283-90. PubMed ID: 7586596
    [Abstract] [Full Text] [Related]

  • 38. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.
    Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC.
    J Psychiatr Res; 2014 Jun 15; 53():76-83. PubMed ID: 24655586
    [Abstract] [Full Text] [Related]

  • 39. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 15; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 40. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun 15; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.